ARTHROPLASTY
Liposomal bupivacaine vs Ranawat suspension injection for postoperative pain after TKA
J Arthroplasty. 2016 Mar;31(3):633-6.105 patients scheduled to undergo total knee arthroplasty were randomized to receive either liposomal bupivacaine or modified Ranawat suspension periarticular injection, for the purpose of determining if either injection treatment was associated with significantly improved postoperative pain, narcotic requirement and functional restoration/improvement. Results demonstrated comparable pain and clinical outcomes at all follow-up intervals up to 6 postoperative weeks, which suggests that both injection treatments were sufficient in postoperative management.
Unlock the full ACE Report
You have access to {0} free articles per month.Click below to unlock and view this {1}
Unlock NowCritical appraisals of the latest, high-impact randomized controlled trials and systematic reviews in orthopaedics
Access to OrthoEvidence podcast content, including collaborations with the Journal of Bone and Joint Surgery, interviews with internationally recognized surgeons, and roundtable discussions on orthopaedic news and topics
Subscription to The Pulse, a twice-weekly evidence-based newsletter designed to help you make better clinical decisions
Exclusive access to original content articles, including in-house systematic reviews, and articles on health research methods and hot orthopaedic topics
Or upgrade today and gain access to all OrthoEvidence content for just $1.99 per week.
Already have an account? Log in
Subscribe to "The Pulse"
Evidence-Based Orthopaedics direct to your inbox.
{0} of {1} free articles
Become an OrthoEvidence Premium Member. Expand your perspective with high-quality evidence.
Upgrade Now
